The Valley Desk

Clinical trial reportGynecologic oncologyPublished

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer

13 of 33 authors shown in byline order.

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Gynecologic oncology
Published
Subject terms
Humans; Ovarian Neoplasms; Disease Progression; Piperidines; Indazoles; Double-Blind Method; Quality of Life; Adult; Aged; Middle Aged; Female; Maintenance Chemotherapy
PubMed ID
42385609
Added to directory
Source checked

Report a correction or request removal